Julio Aguirre-Ghiso Receives 2026 AACR Distinguished Lectureship in Breast Cancer Research
Julio Aguirre-Ghiso/LinkedIn

Julio Aguirre-Ghiso Receives 2026 AACR Distinguished Lectureship in Breast Cancer Research

Julio Aguirre-Ghiso, Associate Director for Basic Science at Montefiore Einstein Comprehensive Cancer Center, has received the 2026 AACR Distinguished Lectureship in Breast Cancer Research. He will be honored at the San Antonio Breast Cancer Symposium 2026 and will deliver his lecture on Thursday, December 10, at 10:45 a.m. CT in Hall 1 of the Henry B. González Convention Center.

The American Association for Cancer Research (AACR) shared the news:

“Dr. Aguirre-Ghiso is being recognized for his pioneering discoveries that have transformed our understanding of cancer dormancy and metastatic relapse. He is renowned for discovering a new field of cancer biology, revealing how disseminated tumor cells can persist in a regulated dormant state even if they harbor cancer-driving mutations.

Further, he expertly uncovered the molecular, microenvironmental, and immune-based mechanisms that control cellular dormancy and reactivation. Through visionary leadership and scientific innovation, he has translated these discoveries into novel therapeutic strategies aimed at preventing metastatic relapse and improving breast cancer patient outcomes.”

Reflecting on the recognition, Julio Aguirre-Ghiso shared:

“No words to explain how thankful and honored I am for this recognition. Thanks to the selection committee at the American Association for Cancer Research and to my fellow nominees, but most important to my laboratory members over the years that have made our research innovative and impactful.

Much more work to be done, and that is why we created the Cancer Dormancy Institute at Montefiore Einstein Comprehensive Cancer Center. THANK YOU!”

About Julio Aguirre-Ghiso

Julio Aguirre-Ghiso is Professor of Cell Biology, Rose C. Falkenstein Chair in Cancer Biology at Albert Einstein College of Medicine and Director of the Cancer Dormancy Institute. He is also a Scientific Founder and Scientific Advisory Board member of HiberCell, a company focused on therapeutics targeting the biology and mechanisms of tumor dormancy. He was also a Professor with Tenure at Mount Sinai School of Medicine.

The full list of award recipients for the 2026 San Antonio Breast Cancer Symposium was announced by AACR.

You can also read:

SABCS 2026: The Top 10 Breast Cancer Studies to Watch for Potential Practice-Changing ResultsJulio Aguirre-Ghiso Receives 2026 AACR Distinguished Lectureship in Breast Cancer Research